Hansa Medical AB revenue breakdown overview

Hansa Medical AB revenue for the last year amounted to 13.24 M USD, the most of which — 13.24 M USD — came from its highest performing source at the moment, Antibody-cleaving Enzyme Technology Platform, the year earlier bringing 14.76 M USD. The greatest contribution to the revenue figure was made by Europe (excluding Sweden) — last year it brought Hansa Medical AB 10.53 M USD, and the year before that — 8.17 M USD.